Skip to main content

Advertisement

SpringerLink
Log in

Safety of Intravenous Thrombolysis within 4.5 h of Symptom Onset in Patients with Negative Post-Treatment Stroke Imaging for Cerebral Infarction

  • Original Article
  • Published:
Neurocritical Care Aims and scope Submit manuscript

Abstract

Background

Patients with stroke symptoms but negative diffusion-weighted imaging (DWI) might have transient ischemic attacks (TIA) or stroke mimics. Brain DWI is important for the diagnosis of cerebral infarction but it is not available before thrombolysis for most patients to avoid treatment delay. This study aimed to evaluate the safety of IV thrombolysis in patients with a negative post-treatment DWI for cerebral infarction.

Methods

We conducted a retrospective study of 89 patients treated with IV recombinant tissue plasminogen activator (rt-PA) within 4.5 h after stroke symptom onset. The patients were identified in our acute stroke registry from January 2009 to September 2010. Information on patients’ demographics, clinical characteristics, neuroimaging, treatment complications, and outcomes was obtained and analyzed.

Results

Out of 89 patients, 23 patients (26%) had a negative DWI on follow-up stroke imaging. Fourteen patients had a TIA and nine patients had a stroke mimic, including Todd’s paralysis, complicated migraine, and somatoform disorder. We found significant differences between patients with a positive and a negative DWI in mean age (62 years vs. 52 years; P < 0.01) and median admission NIH stroke scale score (11 points versus 6 points; P < 0.001). Among patients with a positive DWI, four patients had a symptomatic intracerebral hemorrhage (ICH). No patients with a negative DWI had symptomatic or asymptomatic ICH.

Conclusions

Our results suggest that the administration of IV rt-PA within the first 4.5 h of symptom onset in patients with suspected ischemic stroke is safe even when post-treatment DWI does not demonstrate cerebral infarction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Lees KR, Bluhmki E, von Kummer R, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 2010;375:1695–703.

    Article  PubMed  CAS  Google Scholar 

  2. Schellinger PD, Bryan RN, Caplan LR, et al. Evidence-based guideline: the role of diffusion and perfusion MRI for the diagnosis of acute ischemic stroke: report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology. 2010;75:177–85.

    Article  PubMed  CAS  Google Scholar 

  3. Oppenheim C, Stanescu R, Dormont D, et al. False-negative diffusion-weighted MR findings in acute ischemic stroke. Am J Neuroradiol. 2000;21:1434–40.

    PubMed  CAS  Google Scholar 

  4. Huff JS. Stroke mimics and chameleons. Emerg Med Clin North Am. 2002;20:583–95.

    Article  PubMed  Google Scholar 

  5. Yew KS, Cheng E. Acute stroke diagnosis. Am Fam Physician. 2009;80:33–40.

    PubMed  Google Scholar 

  6. Chernyshev OY, Martin-Schild S, Albright KC, et al. Safety of tPA in stroke mimics and neuroimaging-negative cerebral ischemia. Neurology. 2010;74:1340–5.

    Article  PubMed  CAS  Google Scholar 

  7. Winkler DT, Fluri F, Fuhr P, et al. Thrombolysis in stroke mimics: frequency, clinical characteristics, and outcome. Stroke. 2009;40:1522–5.

    Article  PubMed  Google Scholar 

  8. Uchino K, Massaro L, Hammer MD. Transient ischemic attack after tissue plasminogen activator: aborted stroke or unnecessary stroke therapy? Cerebrovasc Dis. 2010;29:57–61.

    Article  PubMed  CAS  Google Scholar 

  9. Caplan L, Mohr J, Kistler J, Koroshetz W. Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? Thrombolysis—not a panacea for ischemic stroke. N Engl J Med. 1997;337:1309–10.

    Article  PubMed  CAS  Google Scholar 

  10. Scott PA, Silbergleit R. Misdiagnosis of stroke in tissue plasminogen activator-treated patients: characteristics and outcomes. Ann Emerg Med. 2003;42:611–8.

    Article  PubMed  Google Scholar 

  11. Vroomen P, Buddingh M, Luijckx G, et al. The incidence of stroke mimics among stroke department admissions in relation to age group. J Stroke Cerebrovasc Dis. 2008;17:418–22.

    Article  PubMed  Google Scholar 

  12. Hand P, Kwan J, Lindley R, Dennis M, Wardlaw J. Distinguishing between stroke and mimic at the bedside: the brain attack study. Stroke. 2006;37:769–75.

    Article  PubMed  Google Scholar 

  13. Hemmen TM, Meyer BC, McClean TL, Lyden PD. Identification of nonischemic stroke mimics among 411 code strokes at the University of California, San Diego, Stroke Center. J Stroke Cerebrovasc Dis. 2008;17:23–5.

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

The authors wish to express their gratitude to James Roberts, B.S., R.N. for data collection assistance.

Author information

Authors and Affiliations

  1. Department of Neurology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA

    Elias A. Giraldo

  2. Department of Neurology, University of Tennessee Health Science Center, Memphis, TN, USA

    Aisha Khalid & Ramin Zand

Authors
  1. Elias A. Giraldo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Aisha Khalid
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ramin Zand
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elias A. Giraldo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Giraldo, E.A., Khalid, A. & Zand, R. Safety of Intravenous Thrombolysis within 4.5 h of Symptom Onset in Patients with Negative Post-Treatment Stroke Imaging for Cerebral Infarction. Neurocrit Care 15, 76–79 (2011). https://doi.org/10.1007/s12028-011-9523-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12028-011-9523-x

Keywords

Search

Navigation